Insulin affordability and availability across Europe are just part of the complex diabetes management dynamics challenging the EU’s fragile and diverse healthcare systems. Socioeconomic and regional disparities play their part, but so too does innovati…
There is an urgent need to improve access to new innovations in the diagnosis and treatment of Alzheimer’s disease. Embracing breakthroughs such as blood-based biomarker testing, has the potential to transform timely, accurate diagnosis for the benefit…
Europe’s health landscape is in constant motion, and the EU’s digital transformation aims to reset this landscape. The European Health Forum Gastein took stock of today’s challenges and the impact of the ‘3Ds’ – democracy, demographics, and digitalisat…
According to Swedish specialists, prioritising care for osteoporosis patients reduces fractures and saves lives and money. More investment is needed to deal with under-diagnosis and under-treatment in Sweden, they say.
Europe needs a plan to address Alzheimer’s Disease that contains concrete measures, each with its own deadlines, and supported with proper funding, MEP Tomislav Sokol (EPP) told Euractiv.
Progress on Alzheimer’s Disease and dementia is stagnating, Alzheimer Disease International CEO Paola Barbarino has warned, yet it’s the most common form of dementia in Europe’s elderly.
